Pain Management News

As healers, we are most comfortable and confident when we can rely on the long-established armamentarium of countless medications created by the American pharmaceutical industry.

Humans have had an insatiable appetite for inhibiting production of prostaglandins for centuries! This series delves into the history of aspirin and NSAIDs, looking at the understanding of the prostaglandin pathway.

DESTIN, Fla. — Clinical practice guidelines for chronic pain sometimes emerge through flawed processes, present conflicting statements, and warrant close evaluation, according to a speaker at the Congress of Clinical Rheumatology East.

DESTIN, Fla. — Physicians can consider cannabis before opioids for chronic pain when other options have been exhausted, according to a speaker at the Congress of Clinical Rheumatology East.

BOSTON — Aspirin may not be as beneficial vs. other agents for primary CVD prevention following recent research, according to a speaker at the ACP Internal Medicine Meeting.

BOSTON — There is some evidence that cannabinoids may help with neuropathic pain, chemotherapy-induced nausea/vomiting and MS-associated spasticity, “but it’s not exactly a slam dunk,” a speaker said.

BOSTON — Acupuncture can be an effective treatment for several types of pain, according to a speaker at the annual ACP Internal Medicine Meeting.

Physician empathy was inversely associated with several health outcomes among adults with chronic low back pain, such as pain intensity and back-related disability, a study demonstrated.

Aruba Aloe Balm N.V. has recalled 40 lots of its hand sanitizer and aloe products due to methanol contamination, according to an FDA public service announcement.

The release of the 2016 CDC guidelines for prescribing opioids for chronic pain may have had unintended consequences for patients with sickle cell disease, or SCD, a study showed.